BashTheBug reaches one million classifications Philip Fowler, 4th October 20184th October 2018 BashTheBug, a citizen science project I run that is helping us measure how different clinical samples of M. tuberculosis grow in the presence of 14 different antibiotics, reached its first million classifications earlier this week. To read more head over to its blog. The photo mosaic on the left is made up of images sent in by volunteers who’ve all contributed to the success of BashTheBug. Share this: Share on X (Opens in new window) X Share on Bluesky (Opens in new window) Bluesky Email a link to a friend (Opens in new window) Email Share on LinkedIn (Opens in new window) LinkedIn Share on Mastodon (Opens in new window) Mastodon Related antimicrobial resistance citizen science clinical microbiology tuberculosis
antimicrobial resistance Diagnosing antibiotic resistance: future trends? 23rd April 20175th August 2018 It is Sunday, I’m in Vienna at the European Congress of Clinical Microbiology and Infectious… Share this: Share on X (Opens in new window) X Share on Bluesky (Opens in new window) Bluesky Email a link to a friend (Opens in new window) Email Share on LinkedIn (Opens in new window) LinkedIn Share on Mastodon (Opens in new window) Mastodon Read More
antimicrobial resistance New preprint: predicting rifampicin resistance 16th August 202416th August 2024 In this preprint we train a series of machine learning models on protein mutations found… Share this: Share on X (Opens in new window) X Share on Bluesky (Opens in new window) Bluesky Email a link to a friend (Opens in new window) Email Share on LinkedIn (Opens in new window) LinkedIn Share on Mastodon (Opens in new window) Mastodon Read More
antimicrobial resistance BashTheBug Coordinator post advertised 15th November 2019 We are advertising for a Part-time Citizen Science Project Co-ordinator to come and work with… Share this: Share on X (Opens in new window) X Share on Bluesky (Opens in new window) Bluesky Email a link to a friend (Opens in new window) Email Share on LinkedIn (Opens in new window) LinkedIn Share on Mastodon (Opens in new window) Mastodon Read More